These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 5024143)
1. Statistical analysis of the USP 18 content uniformity sampling plan for tablets. Langenbucher F Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143 [No Abstract] [Full Text] [Related]
2. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets]. Tao QF; Zhong DF; Luo X; Wang X Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209 [No Abstract] [Full Text] [Related]
4. Statistical characteristics of the USP content uniformity test. Pedersen AO; Torud Y Pharm Acta Helv; 1971 Feb; 46(2):114-20. PubMed ID: 5142661 [No Abstract] [Full Text] [Related]
5. Dissolution test acceptance sampling plans. Tsong Y; Hammerstrom T; Lin K; Ong TE J Biopharm Stat; 1995 Jul; 5(2):171-83. PubMed ID: 7581426 [TBL] [Abstract][Full Text] [Related]
6. The USP content uniformity test. Analysis and proposals. Setnikar I Pharm Acta Helv; 1974; 49(9-10):302-8. PubMed ID: 4462139 [No Abstract] [Full Text] [Related]
7. Some properties of the USP content-uniformity test as related to control charts and validation of solid dosage forms. Bolton S J Pharm Sci; 1985 May; 74(5):572-4. PubMed ID: 4020637 [TBL] [Abstract][Full Text] [Related]
8. Parametric two-stage sequential quality assurance test of dose content uniformity. Tsong Y; Shen M J Biopharm Stat; 2007; 17(1):143-57. PubMed ID: 17219760 [TBL] [Abstract][Full Text] [Related]
9. Uniformity of content requirements for tablets and capsules. Kendall CE; Low GK; Hailey DM J Pharm Pharmacol; 1981 Apr; 33(4):197-202. PubMed ID: 6115899 [TBL] [Abstract][Full Text] [Related]
10. Stability of nitroglycerin tablets submitted by U.S. hospitals. Crabbs WC; Dow ML; Juhl YH; Page DP Am J Hosp Pharm; 1983 Dec; 40(12):2170-5. PubMed ID: 6419589 [TBL] [Abstract][Full Text] [Related]
11. Lack of medication dose uniformity in commonly split tablets. Teng J; Song CK; Williams RL; Polli JE J Am Pharm Assoc (Wash); 2002; 42(2):195-9. PubMed ID: 11926662 [TBL] [Abstract][Full Text] [Related]
12. Content uniformity and assay requirements in current regulations. Bánfai B; Ganzler K; Kemény S J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871 [TBL] [Abstract][Full Text] [Related]
14. Unit dose sampling and final product performance: an alternative approach. Geoffroy JM; Leblond D; Poska R; Brinker D; Hsu A Drug Dev Ind Pharm; 2001 Aug; 27(7):731-43. PubMed ID: 11694021 [TBL] [Abstract][Full Text] [Related]